About
Novel oral therapeutic for dystonia
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Clinical Trials (1)
View allTotal Trials
1
As Lead Sponsor
1
As Collaborator
0
Total Enrollment
200
By Status
RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2024
2025
2026
2027
Today
Hover over trial bars to see details
Locations (1)
Headquarters
Cambridge, MA, United States
Map
Loading map...